Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.88 USD | +2.61% |
|
+1.84% | -36.19% |
06-03 | Oppenheimer Adjusts Immunovant Price Target to $46 From $50, Maintains Outperform Rating | MT |
05-30 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
3.83B | - | - | - | - | - | |
44.44B | - | |||||
40.03B | ||||||
37.68B | ||||||
31.46B | - | |||||
27.29B |
- Stock Market
- Equities
- IMVT Stock
- Charts Immunovant, Inc.
- Sector Chart